Profilo
John Connelly worked as Vice President-Program & Alliance Management at Voyager Therapeutics, Inc. from 2015 to 2018.
He also worked as Chief Development Officer at Akouos, Inc. Mr. Connelly holds an MBA from Suffolk University and an undergraduate degree from the University of Vermont.
Precedenti posizioni note di John Connelly
Società | Posizione | Fine |
---|---|---|
VOYAGER THERAPEUTICS, INC. | Corporate Officer/Principal | 01/02/2018 |
AKOUOS | Corporate Officer/Principal | - |
Formazione di John Connelly
University of Vermont | Undergraduate Degree |
Suffolk University | Masters Business Admin |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
Società quotate in Borsa | 1 |
---|---|
VOYAGER THERAPEUTICS, INC. | Health Technology |
Aziende private | 1 |
---|---|
Akouos, Inc.
Akouos, Inc. BiotechnologyHealth Technology Akouos, Inc. is a precision genetic medicine company, which engages in the development of precision genetic medicines to restore and preserve hearing in genetically-defined patient populations. The firm's lead product candidate, AK-OTOF, is a gene therapy for the treatment of hearing loss due to mutations in the OTOF gene. It develops targeted adeno-associated viral vector based gene therapies for sensorineural hearing loss, which results from dysfunction or damage to sensory cells and nerve fibers of the inner ear. The company was founded by Emmanuel J. Simons, William F. Sewell, Richard H. Smith, Luk H. Vandenberghe, and Michael J. McKenna on March 7, 2016 and is headquartered in Boston, MA. | Health Technology |
- Borsa valori
- Insiders
- John Connelly